MARGARET WALLACE: Open Payments
NPI 1366877060 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$570 in 29 payments from 13 companies in 2025. Trend: 2023 $1,892 · 2024 $1,302 · 2025 $570
Food & beverage: $570
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 3 | $75 |
| Amgen Inc. | 4 | $67 |
| AstraZeneca Pharmaceuticals LP | 4 | $66 |
| GlaxoSmithKline, LLC. | 3 | $52 |
| Sumitomo Pharma America, Inc. | 2 | $49 |
| Merck Sharp & Dohme LLC | 2 | $49 |
| Lilly USA, LLC | 2 | $45 |
| Exact Sciences Corporation | 2 | $45 |
| Novartis Pharmaceuticals Corporation | 2 | $38 |
| Azurity Pharmaceuticals, Inc. | 2 | $29 |
Products named: REXULTI, OTEZLA, AIRSUPRA, TRELEGY ELLIPTA, GEMTESA, VERQUVO, KISUNLA, Cologuard Collection Kit.
Industry payments across MI — which companies pay providers there.
